WETTIG THANE (Chief Commercial Officer) purchased 36.4% of their position (145K shares) of KYNTRA BIO, INC. on the open market
Open‑market purchase worth $50.7K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/25/2025ACC: 0001415889-25-008872
Officer· Chief Commercial Officer
Since Jun 2020
+145K
Net shares
Net buyer
$50.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
145K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+145K
Price / share
$0.35
Trade value
$50.66K
% of position
36.4%
3/24/2025
398.33K→543.33K
Total
Net shares
+145K
Net value
$50.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2025 | P · Purchase | +145K | $0.35 | $50.66K | 36.4% | 398.33K | 543.33K |
| Total | +145K | $50.66K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1K
Total
1K indirect1K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1K | Indirect |
| Total | 1K | 1K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported